ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA

被引：41
|
作者：
ONISHI, S
SAIBARA, T
FUJIKAWA, M
SAKAEDA, H
MATSUURA, Y
MATSUNAGA, Y
YAMAMOTO, Y
机构：
来源：
HEPATOLOGY | 1989年 / 10卷 / 03期
关键词：
D O I：
10.1002/hep.1840100318
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [41] THERAPEUTIC USES OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    RICHARDS, JM
    BLOOD REVIEWS, 1989, 3 (02) : 110 - 119
  • [42] HYPOTHYROIDISM AFTER TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    ATKINS, MB
    MIER, JW
    PARKINSON, DR
    GOULD, JA
    BERKMAN, EM
    KAPLAN, MM
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (24): : 1557 - 1563
  • [43] Liver metastases from gastric carcinoma: Report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)
    Fabbri, L
    Ridolfi, R
    Riccobon, A
    Maltoni, R
    Flamini, E
    Fedriga, R
    Flamigni, A
    Migliori, G
    Ortolani, F
    Calzolari, F
    Amadori, D
    TUMORI, 1995, 81 (06) : 445 - 449
  • [44] OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    LEITMAN, S
    CHANG, AE
    ETTINGHAUSEN, SE
    MATORY, YL
    SKIBBER, JM
    SHILONI, E
    VETTO, JT
    SEIPP, CA
    SIMPSON, C
    REICHERT, CM
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23): : 1485 - 1492
  • [45] THYROID FUNCTIONS IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    KUNG, AWC
    LAI, CL
    WONG, KL
    TAM, CF
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (297): : 33 - 42
  • [46] ADOPTIVE IMMUNOTHERAPY OF HUMAN PANCREATIC-CANCER WITH LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN A NUDE-MOUSE MODEL
    MARINCOLA, FM
    DAPOZZO, LF
    DRUCKER, BJ
    HOLDER, WD
    SURGERY, 1990, 108 (05) : 919 - 929
  • [47] LYMPHOKINE ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
    EGGERMONT, AMM
    SUGARBAKER, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 363 - 363
  • [48] IMMUNOTHERAPY OF MURINE HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS EXPANDED IN SERUM-FREE MEDIA AND RECOMBINANT INTERLEUKIN-2
    LAFRENIERE, R
    BORKENHAGEN, K
    BRYANT, LD
    HUCHCROFT, S
    CANCER RESEARCH, 1989, 49 (09) : 2409 - 2414
  • [49] EFFECT OF IMMUNOTHERAPY WITH ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2 ON ESTABLISHED PULMONARY AND HEPATIC METASTASES IN MICE
    SHILONI, E
    LAFRENIERE, R
    MULE, JJ
    SCHWARZ, SL
    ROSENBERG, SA
    CANCER RESEARCH, 1986, 46 (11) : 5633 - 5640
  • [50] USE OF HUMAN-LEUKOCYTE ANTIGEN-MISMATCHED ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN THE ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH MALIGNANCIES
    KIMOTO, Y
    TANAKA, T
    TANJI, Y
    FUJIWARA, A
    TAGUCHI, T
    BIOTHERAPY, 1994, 8 (01) : 41 - 50
12345